IMAC Holdings Reports Preliminary Fourth Quarter and Year End 2021 Financial Results and Corporate Update

Revenue increased 26% for quarter and 12% annually

BRENTWOOD, Tenn., March 31, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today reported its preliminary financial results for the year ended December 31, 2021.